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The thrifty ‘catch-up fat’ phenotype: its impact on
insulin sensitivity during growth trajectories to obesity
and metabolic syndrome
AG Dulloo1, J Jacquet2, J Seydoux2 and J-P Montani1
1Division of Physiology, Department of Medicine, University of Fribourg, Switzerland and 2Faculty of Medicine, University of
Geneva, Switzerland
The analyses of large epidemiological databases have suggested that infants and children who show catch-up growth, or
adiposity rebound at a younger age, are predisposed to the development of obesity, type 2 diabetes and cardiovascular diseases
later in life. The pathophysiological mechanisms by which these growth trajectories confer increased risks for these diseases are
obscure, but there is compelling evidence that the dynamic process of catch-up growth per se, which often overlaps with
adiposity rebound at a younger age, is characterized by hyperinsulinemia and by a disproportionately higher rate in the recovery
of body fat than lean tissue (i.e. preferential ‘catch-up fat’). This paper first focuses upon the almost ubiquitous nature of this
preferential ‘catch-up fat’ phenotype across the life cycle as a risk factor for obesity and insulin-related complications – not only
in infants and children who experienced catch-up growth after earlier fetal or neonatal growth retardation, or after preterm
birth, but also in adults who show weight recovery after substantial weight loss owing to famine, disease-cachexia or periodic
dieting. It subsequently reviews the evidence indicating that such preferential catch-up fat is primarily driven by energy
conservation (thrifty) mechanisms operating via suppressed thermogenesis, with glucose thus spared from oxidation in skeletal
muscle being directed towards de novo lipogenesis and storage in white adipose tissue. A molecular–physiological framework is
presented which integrates emerging insights into the mechanisms by which this thrifty ‘catch-up fat’ phenotype crosslinks with
early development of insulin and leptin resistance. In the complex interactions between genetic constitution of the individual,
programming earlier in life, and a subsequent lifestyle of energy dense foods and low physical activity, this thrifty ‘catch-up fat’
phenotype – which probably evolved to increase survival capacity in a hunter–gatherer lifestyle of periodic food shortages – is a
central event in growth trajectories to obesity and to diseases that cluster into the insulin resistance (metabolic) syndrome.
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Weight dynamics and risks for diseases
Dynamic changes in body weight have long been recognized
to be important indicators of risks for later debilitating
diseases. Whereas severe weight loss or impaired growth can
lead to muscle wastage and to increased susceptibility to
infections and organ dysfunctions, the development of
obesity predisposes to type 2 diabetes and cardiovascular
diseases, with insulin resistance as a relatively early deve-
lopment in the pathogenesis of these chronic diseases. In
more recent decades, an increasing body of evidence has also
implicated the dynamic process of recovering body weight –
whether after weight loss or after growth retardation – in the
pathogenesis of these chronic diseases (Figure 1).
Weight recovery after weight loss in adults
High cardiovascular morbidity and mortality have often
been reported in men and women who in young adulthood
experienced marked fluctuations in body weight.1–5 In the
most recently published large population-based study6 in the
US (National Health and Nutrition Examination Survey I,
n¼8479) that included multiple weight measurements
between 1971 and 1992, weight fluctuation was also
associated with a higher risk of all-cause and cardiovascular
mortality, even after adjustment for pre-existing disease,
initial body mass index (BMI) and the exclusion of those in
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poor health and the incapacitated.6 As these associations
were found to be independent of excess weight and trend of
body weight over time, they are hence of clinical relevance
not only for the obese ‘yoyo’ dieters who fail to maintain
their lost weight, but also for non-obese population groups
whose weight fluctuates for a variety of reasons, namely (i)
because of recurring chronic diseases with episodic remis-
sions, such as those suffering from chronic alcoholism and
gastrointestinal diseases, and (ii) because of ‘weight cycling’
behaviors resulting from periodic dieting such as in athletes
engaged in ‘power’ sports with weight categories (wrestlers,
boxers and weightlifters), or in people with perceived, rather
than real, excess weight in the relentless pursuit for thinness
(Ref. Montani et al.,7 for review). In fact, the evidence for
higher cardiovascular risks owing to large swings in body
weight is more compelling in cohorts from the general
population than from obese populations per se. In some of
these former cohorts, even a single cycle of substantial weight
loss and weight recovery in young adulthood was found to be
a risk factor for subsequent coronary heart diseases and
mortality.1,2 These conclusions, which were derived from
retrospective studies in Europe and North America have
recently been strengthened by several long-term studies in
Japan which show increased risk for various components of
the metabolic syndrome (hyperinsulinemia, hypertriglycer-
idemia, high low-density lipoprotein cholesterol, high fasting
glucose and abdominal obesity) both in overweight and in
normal-weight persons with large weight fluctuations.8–10
Catch-up growth after poor fetal or neonatal growth
By far the most compelling evidence linking large fluctua-
tions in body weight as a risk factor for later diseases derive
from longitudinal studies extending throughout an entire
generation in many parts of the world. These epidemiologi-
cal studies have suggested that people who had low birth
weight or whose growth faltered during infancy and child-
hood, but who subsequently showed catch-up growth have
higher susceptibility for the development of obesity, type 2
diabetes and cardiovascular diseases later in life.11–16 For
example, the analysis of data from Finland indicates that
men who were small at birth and thin during infancy but
subsequently showed catch-up growth and became over-
weight in childhood were found to have a fivefold increase
in mortality compared with men with a high BMI at birth
and lean in childhood.11 Further evidence that catch-up
growth, though beneficial in the short term, might be
detrimental in the long term can be derived from studies
conducted in countries undergoing nutrition transition.
Studies from South Africa, Brazil, Russia, China and India
suggest that stunted children have a 2–8 times greater risk of
becoming overweight17 and/or have increased risks for
cardiovascular and metabolic disorders.18–21 Finally in a
detailed retrospective longitudinal study of 8760 men and
women born in Helsinki with records of their monthly
changes in body size from birth to 2 years of age, as well as
annual changes through 11 years of age, it was shown that
men and women who were small at birth and thin during
infancy and subsequently showed catch-up growth had
higher risks of coronary events.16 These higher risks were
also associated with insulin resistance, and were more
strongly related to the tempo of childhood gain in BMI
than to the BMI attained at any particular age, thereby
underscoring the fundamental importance of the dynamic
aspects of catch-up growth per se on later insulin resistance
and cardiovascular risks.
Body
Weight
Age
Growth Adult
Unintentional
weight loss/recovery
‘yoyo‛ dieting Increased risks for 
cardiovascular morbidity 
& mortality
Thin/short at birth
or during infancy
+ Catch-up growth
Early adiposity rebound
Increased risks for later obesity,
hypertension & type 2 diabetes
Increased risks for later abdominal obesity, 
type 2 diabetes & cardiovascular diseases
Figure 1 Schematic representation of risks for chronic diseases resulting from large fluctuations in body weight earlier in life during the growth period (fetal,
neonatal, infancy and childhood) or in young adulthood.
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Catch-up growth after preterm birth
Catch-up growth in those born preterm has also been linked
to insulin resistance later in life. Although the incidence of
obesity, type 2 diabetes or cardiovascular diseases among
people who were born prematurely is unknown (as the first
generation of very premature infants is only now surviving
in substantial numbers), children and adolescents who
showed neonatal catch-up growth after being born pre-
maturely, irrespective of whether they were appropriate for
gestational age (AGA) or small for gestational age (SGA),
have reduced insulin sensitivity and increased circulating
insulin levels22,23 Furthermore, in a prospective long-term
follow-up into young adulthood of men and women born
very preterm, catch-up growth during early infancy was a
predictor of adult fat accumulation24 as well as central fat
distribution and higher insulin levels at 19 years of age.25
Catch-up growth after premature adiposity rebound
These long-term health hazards of catch-up growth also
seem to overlap with another major childhood predictor of
later obesity, that is, an early (younger) age for adiposity
rebound – a term first coined by Rolland-Cachera et al.26 to
refer to the age that corresponds to the second rise in the
BMI curve, and which normally occurs between 5 and 7 years
in the Western world. Investigations in many countries have
confirmed this association between an earlier age for
adiposity rebound (often o3 year) with increased risk for
adult obesity and hypertension.26,27 Furthermore, it has been
shown that, independently of birth weight, a pattern of poor
weight gain before an early adiposity rebound, followed by
increased BMI after the rebound (i.e. catch-up growth after
onset of early adiposity rebound) seems to confer increased
risk for impaired glucose tolerance and type 2 diabetes in
adulthood.28–30 Whether children who have an early
adiposity rebound had a low-weight gain during infancy
because of exposure to a weaning or post-weaning infant diet
that is low in fat but high in protein,31 followed by a
childhood diet that is high in fat, is currently controversial.27
However, as reviewed by Taylor et al.,27 an early age for
adiposity rebound has also been recorded in a number of
pediatric conditions characterized by high subsequent
obesity, including children treated for adrenal 21-hydroxylase
deficiency, hypothyroidism, hyperphenylalaninemia and
acute lymphoblastic leukemia – all conditions that are
generally associated with perturbed growth before the
premature adiposity rebound that overlaps with catch-up
growth.
Catch-up growth: a state of insulin resistance
The mechanisms by which catch-up growth could lead to (or
precipitate towards) such chronic metabolic diseases remain
obscure, amid theories of early (fetal or neonatal) program-
ming which postulate that food deprivation, malnutrition or
other insults, particularly when they occur during critical
periods of growth and development, can lead to lasting
alterations in structures and functions of tissues (namely in
pancreatic b cells, muscle, adipocytes, kidney and liver), and
in the resetting of major neuroendocrine systems.32,33 Such
‘programming’ or ‘imprinting’, although adaptive during
the period of limited supply of nutrients, is thought to
contribute to the increased risks for diseases during im-
proved nutrition and catch-up growth later in life. Whatever
the mechanisms by which such programming may predis-
pose to chronic metabolic diseases, however, several lines of
evidence point to the dynamic phase of catch-up growth per
se as a state of insulin resistance. A higher plasma insulin
response to a glucose load has long been demonstrated
during catch-up growth in infants and children who were
born SGA,34 and more recently, strong associations have
been described in many countries between thinness during
early infancy and an elevated plasma insulin during catch-up
growth later in childhood.35,36 These findings, together with
recent prospective studies from Chile37 indicating that
reduced insulin sensitivity could be related to catch-up
growth in SGA infants as early as at 1 year of age, underscore
the development of insulin resistance as an early feature of
the mechanisms by which catch-up growth might confer
increased risk for later diseases. Whether this early state of
insulin resistance precedes or is preceded by excess adiposity
or preferential abdominal fat deposition is at present
unknown. There is however converging evidence which
suggests that the insulin-resistant state of catch-up growth is
intimately linked with a disproportionately faster rate to
gain body fat rather than lean tissue,38 that is, to a
preferential acceleration of fat recovery or ‘catch-up fat’
The ubiquitous ‘catch-up fat’ phenotype
From a historical perspective, early realization of excessive
fat deposition during catch-up growth in humans can be
traced to the commentary of Widdowson and Shaw39 on
studies conducted in the 1960’s on malnourished children in
Jamaica. They pointed out that when children recovering
from marasmus or marasmic-kwashiorkor in the study of
Ashworth40 had reached their expected weight-for-height,
their bodies contained 25–37% of fat, with a mean value of
30%, which is more than that found by Garrow et al.41 for
clinically well-nourished children in the same age range.
There have been many more reports from nutritional
rehabilitation studies conducted in developing countries
that gains in body weight, even during apparently successful
catch-up growth in infants and children, are largely fat, with
the reconstitution of lean body mass lagging behind.42–47
Catch-up fat in infants/children born SGA
This catch-up fat phenotype, and its association with
hyperinsulinemia and impaired glucose homeostasis, has
more recently been documented in children born SGA in
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developed countries. In a study conducted in Switzerland,
prepubertal children born SGA were found to have more
body fat and less lean tissue, as well as lower glucose
oxidation rates, than weight-matched controls,48 and a
recent longitudinal study in Spain49 has revealed that
already between ages of 2 and 4.5 years, children born SGA
gained more abdominal fat and total body fat (assessed by
dual energy X-ray absorptiometry (DEXA) scan) and less lean
tissue than children born AGA despite similar gains in
weight and BMI (Figure 2a). By about 4 years of age, these
children born SGA had greater adiposity and showed lower
insulin sensitivity than children born AGA.49 Another recent
longitudinal study, using magnetic resonance imaging to
assess adipose tissue volume, indicated that infants born SGA
and showing complete catch-up in relation to head growth
and adiposity by 6 week after birth, still showed incomplete
catch-up in length and weight.50 These differences in body
composition, associated with impaired glucose metabolism,
may persist into adulthood as suggested by studies from
Finland,51 and from England using DEXA scan,52 indicating
that for the same BMI as age-matched controls, healthy
elderly individuals born SGA have 3–5 kg less lean tissue
mass, more fat mass, and a more central fat distribution.
Similarly, studies from Denmark in cohorts of healthy young
men born SGA indicate that they have slightly less lean
tissue mass and slightly more body fat, but clearly higher
abdominal fat mass53 than age-matched controls of similar
BMI, or that they showed reduced forearm glucose uptake54
and reduced muscle expression of key proteins involved in
insulin signaling and glucose transport.55 It is presently
unknown whether these insulin-related impairments in
adults born SGA precede or are preceded by preferential
abdominal fat deposition, excess circulating lipids or ectopic
fat storage, all of which have been implicated in the
development of insulin resistance. However, these studies
in infants, children and adults born SGA point to an early
but long-lasting impairment in glucose homeostasis and
body composition that can be related to preferential catch-
up fat during catch-up growth.
Catch-up fat in infants born preterm
There is also evidence that the phenomenon of preferential
catch-up fat also occurs during catch-up growth in infants
born preterm – a population group that has been reported to
show reduced insulin sensitivity and compensatory hyper-
insulinemia in childhood, adolescence and early adult-
hood.22–25 Indeed, the application of whole-body magnetic
resonance – that allows adipose tissue imaging and its
quantification – has indicated that in infants born extremely
preterm (o32 week gestational age) and profoundly defi-
cient in adipose tissue, the subsequent accelerated post-natal
growth was accompanied by accelerated fat gain such that, at
their expected time of delivery several weeks later, these
b
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Figure 2 Longitudinal studies of human body composition demonstrating preferential catch-up fat in infants born SGA (n¼ 29) compared to controls born AGA
(n¼ 22) (a), and in adults recovering weight after semistarvation in the Minnesota Experiment (b). The figures in panel (a) (Barcelona infants) are derived from data
on body weight and body composition (lean body mass and %fat) assessed by DEXA scan in the study of Ibanez et al.49 Note that (i) the velocity of fat gain (slope of
fat mass vs age) is about twofold greater in the infants born SGA than in controls born AGA, and that (ii) the relatively constant ratio of fat mass to lean tissue mass in
infants born AGA contrasts sharply with the marked quasilinear increase in this ratio in infant born SGA over the 2-year period of body composition study. The figure
in (b) (Minnesota men) is derived from a reanalysis of body composition data (assessed by underwater weighing) after 12 weeks of restricted refeeding on a low-fat
diet in the 32 men participating in the Minnesota study of experimental semistarvation of Keys et al.62; by the time the recovery of fat mass is 100%, the recovery of
lean body mass is still below 50%.74
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preterm infants reached the same total adiposity as term-
born infants despite the fact that they were lighter and
shorter.56 Taken together, these studies further underscore
the occurrence of preferential catch-up fat with lean tissue
lagging behind in preterm infants showing post-natal catch-
up growth, and their predisposition to insulin resistance
later in life.
Catch-up fat in children showing early adiposity rebound
As emphasized above, an early age for childhood adiposity
rebound, which is also a risk factor for later obesity, diabetes
and hypertension, is often reported to be preceded by low-
weight gain during infancy. However, because childhood
adiposity rebound is determined using serial measurements
of BMI, it has been questioned as to whether early rebound
reflects greater relative weight gain or reduced height
velocity, and whether the actual change in body composi-
tion occurring during this time is a reflection of increased
body fat or increased lean body mass.57 There is now
evidence from longitudinal studies in children that differ-
ences in BMI during the period of adiposity rebound are
caused specifically by alterations in weight velocity rather
than in height velocity,58 and in body fat rather than in lean
body mass,59 and that children undergoing early adiposity
rebound gained fat at a faster rate than children who
rebounded at a later age.59 It follows therefore that children
showing an early age for adiposity rebound following low-
weight gain also exhibit the preferential catch-up fat
phenotype that is characteristic of catch-up growth.
The catch-up fat phenotype in adults
The phenomenon of preferential catch-up fat – that is,
disproportionate rate in recovering fat mass relative to lean
tissue mass – has in fact been pointed out since the turn of
the 20th century in adults recovering weight after diseases
or famines.60–62 In particular, Debray et al.61 noted that the
early increase in the weight of prisoners transferred from
German concentration camps to a Paris hospital in a
condition of severe starvation was largely owing to the
accumulation of fat rather than to the rebuilding of muscles.
Keys et al.62 in their study on long-term experimental
semistarvation and refeeding in conscientious objectors of
war found that when body fat was 100% recovered, the
recovery of muscle mass or fat-free mass (FFM) was less than
40% of prestarvation values (Figure 2, panel b). By the time
that FFM had been fully recovered, body fat had exceeded
the prestarvation values by more than 75%.62,63 These
findings led Keys et al.62 to describe such preferential fat
accumulation and fat overshooting as ‘post-starvation
obesity’. Some 50 years later, a similar conclusion was
reached by Weyer et al.64 in their follow-up study of men
and women who lost about 15% of their body weight during
exposure to modest energy restriction sustained over 2
years during confinement in Biosphere 2, a self-contained
ecological ‘miniworld’ and prototype planetary habitat built
in Arizona. Although their body weight returned to pre-entry
values 6 months after exit, the weight regained was found to
be almost exclusively accounted for by an increase in body
fat. Over the past few decades, this phenomenon of fat
recovery predominating over muscle reconstitution has also
been reported in hospitalized adult patients recovering from
severe weight losses owing to poverty-related undernutri-
tion,65 anorexia nervosa66 and various pathophysiological
‘hypermetabolic’ conditions including cancer,67 septic
shock68 acquired immunodeficiency syndrome69 and Par-
kinson’s disease in the elderly.70 Specifically in the case of
women with anorexia nervosa (illness that often begin
during adolescence), normalization of body weight is often
reported to be associated with a central adiposity phenotype,
assessed as increased truncal fat and visceral adipose tissue.71
Regulation of fat storage during catch-up fat
Thus, the preferential catch-up fat phenotype is a common
denominator in many situations of large weight fluctuations –
whether during catch-up growth in infants and children
born preterm, AGA or SGA, or during weight recovery in
young and elderly adults. A fundamental question that arises
therefore is what is known about the processes that regulate
the body fat stores during preferential catch-up fat, and how
do these processes confer increased susceptibility to the
development of insulin resistance?
Control systems regulating catch-up fat
From a standpoint of systems physiology, there are three
fundamental autoregulatory control systems that could be
implicated in catch-up fat:
(i) An overcompensatory hyperphagic drive, particularly
during catch-up growth or weight recovery on energy-
dense foods rich in fats and refined carbohydrates,
(ii) a shift in the control of the body’s partitioning of energy
from lean to fat tissue, particularly with diets that may
be inadequate in specific nutrients (protein, minerals,
vitamins and so on) for optimal protein synthesis, and
(iii) an increase in the efficiency of the metabolic machi-
nery, that is, energy conservation through the suppres-
sion of thermogenesis – which is embodied in the
concept of a ‘thrifty metabolism’.
They may all contribute to the accelerated rate of fat
recovery whether during growth or adulthood. There is
indeed some evidence to suggest that post-natal catch-up
growth may be driven by hyperphagia, as indicated by early
feeding studies in infants,72 and that the occurrence of
refeeding hyperphagia in children and adults is driven by the
impetus to recover both fat mass63 and lean body mass.63,73
However, the phenomenon of preferential catch-up fat can
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be shown to occur in the absence of hyperphagia,38,74 and
without a shift in energy partitioning from lean to fat
tissue,74 which therefore underscore a central role for an
enhanced metabolic efficiency (i.e. suppressed thermo-
genesis) as a fundamental physiological reaction to growth
retardation or weight loss. There are therefore close associa-
tions between weight recovery/catch-up growth, a high
metabolic efficiency underlying catch-up fat, and the
development of obesity and/or insulin-related complica-
tions later in life. Consequently, it follows that sustained
reduction in energy expenditure per se (owing to suppr-
essed thermogenesis in certain organs/tissues) – for the
purpose of enhancing the efficiency of fat recovery – is also
involved in the pathogenesis of these chronic metabolic
diseases.
Role of ‘adipose-specific’ suppression of thermogenesis
There is indeed converging evidence from experimental
studies of prolonged starvation and refeeding in adult
humans62,64,74 and in actively growing animals,75–82 that
an elevated efficiency for catch-up fat is a phenomenon that
occurs at all ages, and that it is a carryover effect of the
suppression of thermogenesis (i.e. energy conservation
mechanisms) that occurred in the preceding period of food
deprivation. This has been referred to as adipose-specific
control of thermogenesis’;83 that is, a control system that
has a slow time-constant by virtue of its response to signals
arising only from the state of depletion (or delayed
expansion) of the body’s fat stores. In this autoregulatory
feedback system, signals from the depleted adipose fat stores
exert a suppressive effect on thermogenesis. Support for the
existence of a control system linking depletion of fat stores
and suppressed thermogenesis in humans comes from the
reanalysis74,84 of longitudinal data on changes in basal
metabolic rate (BMR) and in body composition from the
classic ‘Minnesota Experiment’ of semistarvation and refeed-
ing.62 In this study, 32 healthy men of normal body weight
were subjected to 24 weeks of semistarvation (during which
they lostB25% of initial body weight), followed by 12 weeks
of restricted refeeding on diets relatively low in fat (B20%
fat by energy). As shown in Figure 3, there is a positive
relationship between the deviation in body fat and the
change in adjusted BMR, an index of altered thermogenesis
calculated from the change in BMR after adjusting for losses
of FFM and fat mass. In other words, the greater the degree
of fat depletion during starvation, the greater the reduction
in adjusted BMR and hence in the degree of suppression of
thermogenesis. A similar relationship was also found after
the 12-week period of restricted refeeding, that is, the lower
the degree of fat repletion, the greater the extent of
reduction in residual BMR and hence the greater the degree
of reduction in thermogenesis.84 Taken together, the rela-
tionship between suppressed thermogenesis and fat deple-
tion during phases of both weight loss and weight recovery
indicates the operation of a control system with a negative
feedback loop between thermogenesis and the state of
depletion of fat stores. Although similar type of evidence
linking fat depletion (or delayed expansion of the fat stores)
and suppressed thermogenesis during catch-up growth in
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Figure 3 Minnesota Experiment of human starvation and refeeding revisited: the relationship between suppressed thermogenesis, assessed as change in BMR
adjusted for changes in FFM and fat mass, and the state of depletion of body fat stores during weight loss (S12, week 12 of semistarvation) and weight recovery (R12,
week 12 of restricted refeeding). The relationship between suppressed thermogenesis and fat depletion during phases of both weight loss and weight recovery
suggests the operation of a control system with a negative feedback loop between thermogenesis and the state of depletion of fat stores. Adapted from Refs. Dulloo
and Jacquet.83,84
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humans is not available, direct evidence for an adipose-
specific suppression of thermogenesis, the role of which
is to specifically accelerate body fat recovery, can be derived
from studies of complete energy balance in growing rats
regaining weight after semistarvation (Figure 4). Under
conditions whereby the rehabilitated animals were pair-fed
to weight-matched controls, the rate of protein deposition
was found to be the same as in controls, but that of fat
deposition was increased by more than twofold. This was
shown to be the result of 10–15% lower energy expenditure
during the first 2–3 weeks of isocaloric refeeding.79,80,83 A
number of factors that could theoretically contribute to
this difference in energy expenditure between refed and
control animals (age difference, physical activity and feeding
pattern) have been evaluated and shown to have a minimal
impact on the difference in energy expenditure between
the two groups. Consequently, under these conditions of
refeeding, the lower energy expenditure in the refed animals
is essentially a result of energy being spared owing to
sustained suppression of thermogenesis for the purpose
of catch-up fat. Taken together, these findings in humans
and in animals support the existence of an autoregu-
latory control system that participates in the regulation of
catch-up growth by sustained suppression of thermogenesis,
and suggest that the energy thus conserved is directed
specifically for the recovery of fat mass rather than that of
lean mass, that is, a thrifty metabolism specific for prefer-
ential catch-up fat.
The thrifty metabolism that drives catch-up fat:
impact on insulin sensitivity
As skeletal muscle is an important site for energy conserva-
tion during starvation,62,64,85–88 the control system under-
lying this adipose-specific control of thermogenesis could
operate as a feedback loop between adipose tissue trigly-
ceride stores and skeletal muscle metabolism. As depicted
in Figure 5, it could comprise a sensor(s) of the state of
depletion (or delayed expansion) of the fat stores, signal(s)
dictating the suppression of thermogenesis as a function of
the state of depletion of the fat stores, and an effector system
mediating thermogenesis in skeletal muscle.83 At present,
our understanding of the components of this system is
fragmentary. However, as skeletal muscle is the major site for
insulin-mediated glucose disposal, a reduction in the meta-
bolic rate of muscle would therefore result in a reduction in
glucose utilization, leading to hyperinsulinemia.89 This in
turn, would serve to redirect the spared glucose towards de
novo lipogenesis and fat storage in adipose tissue.
Muscle-adipose glucose redistribution
Support for this ‘glucose redistribution hypothesis’ can be
derived from studies in our animal model of catch-up fat
driven solely by suppressed thermogenesis. These have
indicated that refeeding on a low-fat diet resulted in a more
pronounced elevation in plasma insulin after a glucose
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Figure 4 Sustained reduction in energy expenditure and accelerated fat deposition (catch-up fat) in a rat model of controlled refeeding after semistarvation.
Changes in body composition and in energy balance were assessed over three successive periods of 10 days in refed animals pair-fed to weight-matched (WM)
controls. The lower energy expenditure during refeeding persists for 2–3 weeks, and is due almost entirely to a sustained suppression of thermogenesis that drives
catch-up fat during weight recovery; **Po0.01; ***Po0.001 compared with WM controls. Adapted from Ref. Dulloo and Jacquet.83
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load,90 and that under conditions of hyperinsulinemic–
euglycemic clamps in vivo, insulin-stimulated glucose utiliza-
tion in refed animals is lower in skeletal muscle but higher in
white adipose tissue,91 thereby suggesting a state of insulin
resistance in skeletal muscle and insulin hyperresponsive-
ness in white adipose tissue. Furthermore, the fact that fatty
acid synthase activity is higher in white adipose tissue from
refed animals than from controls, suggest enhanced conver-
sion of glucose to lipids in the adipose tissue fat stores.91 Of
particular importance in these studies comparing refed and
control animals is that this redistribution of glucose utiliza-
tion away from skeletal muscle towards de novo lipogenesis
and fat storage in adipose tissue can be demonstrated in the
absence of between-group differences in energy intake, lean
tissue mass, total body fat mass, regional fat distribution or
in circulating free fatty acids. Similarly, the state of insulin
resistance in skeletal muscle of the refed animals cannot be
attributed to excess lipid storage in muscle cells, as
histological staining of muscles revealed that intramyocel-
lular lipid content in muscles from refed animals was not
higher than in controls.91 Taken together, these data suggest
that the muscle insulin resistance and adipose tissue insulin
hyperresponsiveness in the refed animals are not related to
an excess substrate (free fatty acid) supply or to increased
body fat or ectopic fat storage, but can be linked to the state
of suppressed thermogenesis per se. In other words, the
mechanisms that lead to suppressed skeletal muscle thermo-
genesis (in favor of catch-up fat) are interlinked with those
that lead to insulin resistance during catch-up growth. By
what molecular mechanisms this suppression of thermo-
genesis is brought about, and how these mechanisms of
suppressed thermogenesis might crosslink with early deve-
lopment of skeletal muscle insulin resistance are therefore
fundamental issues that need to be addressed towards
understanding how catch-up growth confers increased
susceptibility to insulin resistance and hyperinsulinemia.
Molecular crosslinks between suppressed thermogenesis and
insulin resistance
As the concentrations of key ‘adiposity’ hormones that
might be implicated in the link between glucose metabolism
and thermogenesis in skeletal muscle (namely insulin and
leptin) are rapidly restored to control levels upon transition
from starvation to refeeding,89,90 our current working
hypothesis, therefore, is that the suppression of thermo-
genesis and concomitant insulin resistance in skeletal
muscle are brought about through the inhibition of
mechanisms by which these (and other) hormones interact
to activate thermogenesis in skeletal muscle.89 Although the
nature of these postulated adipose-specific signal(s) that
inhibit thermogenesis in skeletal are unknown, there is
emerging evidence that their inhibitory actions on muscle
thermogenesis could occur through interference with the
activation of phosphatidylinositol 3-kinase (PI3K) or AMP-
activated protein kinase (AMPK). Indeed, ex-vivo studies of
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Figure 5 Schematic diagram depicting mechanisms by which the thrifty catch-up fat phenotype, driven by the adipose-specific suppression of thermogenesis, may
crosslink with early development of insulin and leptin resistance. The model is built upon emerging evidence that an important thermogenic effector system in
skeletal muscle is mediated by substrate cycling between de novo lipogenesis and lipid oxidation,93,94 and it is orchestrated by PI3K and AMPK under the influence of
insulin, leptin, adiponectin and other hormones (e.g. urocortins).93,94,98 These hormones can interact to stimulate thermogenesis via the enhancement of AMPK and
PI3K signaling either by acting directly on skeletal muscle, or centrally through the sympathetic-thyroid axis via norepinephrine (NE) and triiodothyronine (T3). By
interfering with PI3K and/or AMPK signaling in skeletal muscle, the actions of the adipose-specific signal(s) that sense the state of depletion (or delayed expansion) of
the adipose tissue fat stores will suppress skeletal muscle thermogenesis, which during refeeding will lead to concomitant insulin and leptin resistance. The resulting
hyperinsulinemia serves to redirect the glucose spared from oxidation in skeletal muscle towards de novo lipogenesis and fat storage in white adipose tissue.
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microcalorimetry in intact skeletal muscle have shown that
PI3K and AMPK signaling – which are well known to
influence insulin sensitivity in this tissue – are both required
for hormonal stimulation of thermogenesis in this tissue as
the direct thermogenic effects of leptin or corticotropin-
releasing hormone in skeletal muscle can be inhibited by
selective inhibitors of either AMPK or PI3K.92–94 On the basis
of these findings, it follows that either diminished PI3K
and/or AMPK signaling in skeletal muscle could constitute
impairments that are common to pathways that lead to both
suppressed thermogenesis and to resistance to the actions of
insulin and leptin during catch-up growth (Figure 5). This
notion is indeed supported by data from our laboratory95
indicating diminished basal and insulin-stimulated PI3K
activity in skeletal muscle of rats showing catch-up fat driven
by suppressed thermogenesis during refeeding on a low-fat
diet, with additional impairments in leptin-induced activa-
tion of AMPK during isocaloric refeeding on diets high in
saturated fats.
Which molecular effectors of skeletal muscle thermo-
genesis might be under the control of PI3K and AMPK
signaling, and what factors contribute to such early impair-
ments in these signaling pathways (i.e. impairments that
precede excess adiposity, circulating FFAs or intramyocellular
lipids) are questions that have only recently been the subject
of investigations. Of particular interest is demonstration that
rats showing catch-up fat owing to suppressed thermogen-
esis also show diminished mitochondrial mass and oxidative
capacity specifically in the subsarcolemmal compartment of
skeletal muscle.96 Given the important role that subsarco-
lemmal mitochondria have for bioenergetic support of signal
transduction and substrate transport,97 the possibility arises
that deficiency in this subpopulation of mitochondria could
contribute to impaired PI3K and AMPK signaling. Although a
reduction in the number of subsarcolemmal mitochondria
per se could contribute to the suppression of thermogenesis
that favors catch-up fat, impairments in PI3K or in AMPK
could also lead to a slow down of a ‘futile’ substrate cycling
between de novo lipogenesis and lipid oxidation. This
thermogenic effector has recently been implicated in
hormonal control of skeletal muscle thermogenesis, with
PI3K being required in controlling the flux of substrates
through de novo lipogenesis, and AMPK being required in
controlling the flux of de novo synthesized fatty acids
through mitochondrial b oxidation.93,94,98
A role for stearoyl-CoA desaturase (SCD1), the enzyme that
catalyzes the synthesis of monounsaturates from saturated
fatty acids (in particular from de novo synthesized fatty
acids), has also been implicated in the control of this ‘futile’
substrate cycle, albeit during catch-up fat on a high-
carbohydrate (low-fat) diet. This follows the demonstration
that SCD1, which is known to be markedly repressed by
thermogenic hormones (e.g. leptin and thyroid hormones),
is upregulated in skeletal muscle of rats showing catch-up fat
driven by suppressed thermogenesis during refeeding on
a high-carbohydrate chow diet.99 Such an elevated skeletal
muscle SCD1, by desaturating the products of de novo
lipogenesis and diverting them away from mitochondrial
oxidation, would also result in the slowing down of the
substrate cycling between de novo lipogenesis and lipid
oxidation thereby contributing to the suppression of
thermogenesis that drives catch-up fat. Furthermore, as the
SCD1-derived monounsaturates in skeletal muscle from
animals refed the high carbohydrate diet are channeled
towards the phospholipids (membrane) fraction,99 and as
SCD1 overexpression in skeletal muscle cells leads to
impaired insulin signaling,100 an upregulated SCD1 can also
be implicated in the mechanisms that crosslink suppressed
thermogenesis and insulin resistance in skeletal muscle. Of
particular relevance in this context are the findings that the
enhanced thermogenesis in mice lacking SCD1 can be
associated with increases in the activities of skeletal muscle
PI3K and AMPK.101–102
Overall therefore, there is emerging evidence for insulin
and leptin resistance in the early phase of catch-up fat, and
for impairments in PI3K and AMPK signaling in skeletal
muscle in the mechanisms by which suppressed thermogen-
esis might crosslink with insulin resistance during catch-up
growth. Consequently, impairments in these signaling path-
ways in skeletal muscle may constitute the molecular basis
by which the thrifty metabolism (suppressed thermogenesis)
that accelerates fat recovery confers enhanced susceptibility
to the development of insulin resistance and hyperinsuline-
mia during catch-up growth.
Thrifty metabolism driving catch-up fat: adaptive,
maladaptive and early programming
It can be argued that the biological significance of this thrifty
metabolism underlying catch-up fat – characterized by
concurrent hyperinsulinemia, skeletal muscle insulin resis-
tance and adipose tissue insulin hyperresponsiveness – is to
achieve both blood glucose homeostasis and the rapid
replenishment of the fat stores by diverting glucose spared
from oxidation in skeletal muscle to lipogenesis and fat
storage in adipose tissue. Under conditions of intermittent
periods of food availability that prevailed during much of
mammalian evolution, this coordinated redistribution of
glucose from muscle to adipose tissue probably had survival
value as it enables the rapid replenishment of fat stores, and
hence rapid restoration of survival capacity, without com-
promising blood glucose homeostasis. Despite its ‘adaptive’
nature within the context of a lifestyle of famine-and-feast,
this state may have deleterious consequences in the context
of the modern lifestyle, characterized by low physical
activity and energy-dense diets rich in fat and refined
carbohydrates. In fact, a shift in diet from complex
carbohydrates to animal fat and refined carbohydrates leads
to an exacerbated suppression of thermogenesis, a more
pronounced state of hyperinsulinemia, hyperglycemia and
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excess adiposity in animals recovering weight, compared
with fed controls growing spontaneously on isocaloric
amounts of the same high-fat diet.90 As depicted in Table 1,
high levels of (saturated) fat in the diet, even in the absence
of hyperphagia, has compromised a complex homeostatic
system. To what extent this disruption of glycemia resides in
an exacerbated state of skeletal muscle insulin resistance
and/or in the inability of adipose tissue to dispose of excess
glucose spared as a result of an exacerbated suppression of
thermogenesis during high-fat refeeding is currently under
investigation. Whatever the answers to these questions,
however, it is clear that as the phase of weight recovery/
catch-up growth may last for several months to several years
in humans,16,62 the drive to suppressed thermogenesis for
the purpose of sparing glucose for catch-up fat, via its
orchestration through insulin resistance in skeletal muscle
and altered insulin responsiveness in adipose tissue, con-
stitute a thrifty phenotype that predisposes individuals with
catch-up growth to insulin resistance and risks for later
metabolic syndrome. That such thrifty metabolism may also
be programmed earlier in fetal or neonatal life, and hence
long-lasting so as to operate beyond the phase of catch-up
growth seems plausible in the light of evidence, depicted in
Figure 6, indicating a lower resting energy expenditure (even
after adjustments for weight, height or lean tissue mass) in a
group of elderly adults with low birth weight and showing a
twofold greater prevalence of metabolic syndrome than in
those with a high birth weight.103 In the complex interac-
tions between the genetic constitution of the individual,
programming or imprinting early in life, and a subsequent
lifestyle of energy dense foods and low physical activity, the
thrifty ‘catch-up fat’ phenotype – which evolved to increase
survival capacity in a hunter–gatherer lifestyle of periodic
food shortages – is a central event in growth trajectories to
obesity and to diseases that cluster into the insulin resistance
(metabolic) syndrome.
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Figure 6 Extent of suppressed thermogenesis (thrifty metabolism) in the compartments of resting energy expenditure (REE) in young men or rats showing
preferential catch-up fat after semistarvation, as well as in weight-stable healthy elderly men with low-birth weight. The reduction in adjusted REE is relative to
control values set at 100% (dotted line). Note: (a) the value for extent of suppressed thermogenesis (as % of baseline BMR) in healthy young men recovering body
weight after semistarvation is derived from the Minnesota Experiment of Keys et al.,62 and were determined in a reanalysis of the data on their BMR after adjustments
for changes in FFM and in fat mass relative to prestarvation values,74,84 (b) in rats showing catch-up growth after post-weaning semistarvation, REE is taken as their
total energy expenditure (essentially sedentary) relative to that of weight-matched controls consuming the same amount of energy and gaining protein mass at the
same rate, whether during refeeding on a low-fat diet or on an isocaloric diet rich in animal saturated fat,79,90 and (c) in the group of healthy elderly men with low-
birth weight relative to another group with high-birth weight, REE was determined from measurements of both preprandial and post-prandial REE adjusted for body
weight and height; in this study by Kensara et al.,103 the adjustements of REE for FFM, muscle mass, non-muscular (fat-free soft tissue) mass, or for the ratio of muscle
to non-muscle (fat-free soft tissue) mass also yielded lower REE values (by 8–12%) in the low-birth weight group than in the high birth-weight group.
Table 1 Role of suppressed thermogenesis in susceptibility to hyperinsuli-
nemia and glucose intolerance during catch-up fat in the rat
Refeeding
diets
Thermogenesis Rate of fat
gain
Plasma insulin
concentrations
Glucose tolerance
Low fat k m m Normal (euglycemic)
High fat kk mm mm Impaired
(hyperglycemic)
k: suppressed; kk: further suppressed; m: elevated; mm further elevated. Data
summarized from Ref. Crescenzo et al.90
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